Distribution

New York Pharmaceutical Distributor Caught with Counterfeit Avastin

The FDA is warning physicians to be on the lookout for fake versions of Roche’s cancer drug.

The Food and Drug Administration is warning doctors about another counterfeit version of the cancer drug Avastin distributed in the U.S., the third case involving the best-selling Roche drug in the past year.

No votes yet

New York Pharmaceutical Distributor Caught with Counterfeit Avastin

The FDA is warning physicians to be on the look out for fake versions of Roche’s cancer drug.

The Food and Drug Administration is warning doctors about another counterfeit version of the cancer drug Avastin distributed in the U.S., the third case involving the best-selling Roche drug in the past year.

No votes yet

H. D. Smith Asks Tim Booth to Oversee Smith Medical Partners' Operations, Sales

Pharmaceutical wholesaler H. D. Smith has appointed Tim Booth to executive vice president, Smith Medical Partners. Smith Medical Partners is a wholly owned subsidiary of H. D. Smith, providing specialty pharmaceutical distribution. It is part of the newly formed H. D. Smith Specialty Solutions group.

 

Mylan Specialty, Pfizer Partner on Japanese Distribution of EpiPen

Pfizer will obtain the right to market and sell the epinephrine injection pen in Japan.

Mylan Specialty L.P., a subsidiary of Mylan Inc., and Pfizer Inc. today announced a license agreement, under which Pfizer will obtain the exclusive rights to market and sell EpiPen Injection 0.3/0.15mg in Japan. These products, known in the U.S. as EpiPen (epinephrine) 0.3mg and EpiPen Jr (epinephrine) 0.15mg Auto-Injectors, are for self-administration for the emergency treatment of life-threatening allergic reactions (anaphylaxis) caused by allergens, exercise or unknown triggers. EpiPen Injection is the only approved epinephrine auto-injector in Japan.

No votes yet

ThermoSafe Brands, ISCLabs Details Two Ambient-Temperature Profiles in Whitepaper

ThermoSafe Brands, ISCLabs, is offering a whitepaper addressing the scientific properties of two ambient temperature profiles designed for the safe and viable distribution of temperature-sensitive products.

Pharmaceutical Maker Upgrades Software at Distribution Center in Turkey

ROC IT Solutions reports that a major pharmaceutical manufacturer has upgraded its implementation of ROC IT Solutions technology for track and trace in Turkey. The company's distribution center in Turkey first deployed ROC IT Solutions software in 2009 to meet the Turkish Ministry of Health (MoH) directive for item-level serialization and upgraded after its parent company began using a newer version of ROC IT solutions in the United States.

Accuristix Acquires Nova Pack Ltd.

Accuristix has acquired Nova Pack Ltd., a contract packaging, repackaging, and assembly provider for over-the-counter (OTC), health and beauty, healthcare, and pharmaceutical products. Accuristix is a third-party logistics company currently operating four distribution centers in the Toronto Area, with others in Vancouver and Los Angeles. The acquisition allows both companies to offer a broader scope of services to the Canadian healthcare marketplace.

COMAR Announces Acquisition of Universal Container Corporation

Comar Inc. (Buena, NJ) announced that on Fri., April 16, 2010 it finalized a transaction acquiring 100% of Universal Container Corp.'s (Unicon) assets from its current shareholders. Based in Cayey, Puerto Rico, Unicon is a leading manufacturer of high quality injection molded, injection blow molded, and extrusion blow molded parts and containers. Comar, based in Buena, New Jersey, is a manufacturer of proprietary pharmaceutical packaging with a leadership position in the Liquid Medication Delivery Device Market. The transaction closed on April 16, 2010 and the terms were not disclosed.

Upp Technology Enhances irms|EM Software

Based on feedback from public health agencies and first responders, Upp Technology Inc. (Downers Grove, Ill.) enhances the company’s award-winning irms|EM (Emergency Management) software. The new irms|EM product enhancements streamline the order fulfillment and distribution process of H1N1 vaccines and Personal Protective Equipment (PPE) to partner agencies, private facilities, and the general public.

"Our collaborative, hands-on approach to business allows us to understand our client’s mission and provide them with sustainable business value,” says Carl Brewer, president of Upp Technology (upp.com). “With 10 states slotted to complete the upgrade in September, irms|EM will be well positioned to handle the upcoming H1N1 vaccine distribution."

Unclear Rules Aren't Holding Up Transport Tests

Daphne Allen

Distribution testing requirements can often be unclear, but a majority of medical device professionals perform and validate such tests, a recent survey found. Marci-Ann Ando from Celera Diagnostics presented survey results during MD&M West 2006’s packaging validation conference. Ando conducted the survey as part of her master’s project for Michigan State University.

No votes yet
Syndicate content